Conclusion
ARDS
ARDS
In conclusion, plasma MMP-3 levels demonstrated a prognostic relationship to ARDS mortality. Additionally, MMP-3 elevations from baseline may represent a phenotype of patients with elevated mortality risk. MMP-3 warrants further evaluation as a lung-specific biomarker for predicting treatment benefits among interventions known to improve mortality in ARDS. Future studies should include MMP-3 as a component in phenotyping and predictive methods.